AnnJi
安基生技新藥股份有限公司
AnnJi is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| AJ201 | — | — | — | — | 2026-10-03 | Company disclosure |
| AJ302 | — | Phase 1; completed | Healthy Volunteers | United States | 2025-12-29 | Trial registry |
| AJ305 | — | — | — | — | — | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.